About
IMBiotechnologies is a privately held Canadian biotechnology company whose focus is commercializing medical device products in the area of embolotherapy. IMBiotechnologies' lead product is Ekobi 500 Embolization Microspheres. It is a first in class biodegradable embolic agent that is visible by ultrasound. Ekobi 500 is a medical device cleared by the FDA for the treatment of hypervascularized tumors.
Technologies
YouTube
Linkedin Widget
Apache
Linkedin Login
QuickBooks
Keywords
embolic agents
medical device
microspheres
medical equipment manufacturing
poly(lactic-co-glycolic acid)
vascular tumor treatment
ultrasound detectable
biodegradable embolic microspheres
healthcare
tissue devitalization
tumor embolization
benign prostatic hyperplasia
ekobi microspheres
medical equipment and supplies manufacturing
treatment of bph
biotechnology
tissue-specific embolization
urology
treatment of uterine fibroids
medical device innovation
ultrasound detection in embolotherapy
gastric artery embolization
ultrasound visibility
embolic microspheres
biodegradable embolic agent
clinical trials
ostearthritic joint pain treatment
embolotherapy
tumor treatment
ultrasound-guided embolization
Company Information
-
Employees 2
Location
9650 20 Ave NW, Edmonton, Alberta, Canada, T6N 1G1
